Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Therapix Biosciences Ltd
Nov 13, 2019
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
Dec 11, 2018
Therapix Biosciences Provides Update Regarding FSD Acquisition
Nov 29, 2018
Therapix Biosciences Clarifies Terms of Recently Issued Convertible Debenture
Nov 27, 2018
Therapix Biosciences Issues $1,500,000 Convertible Debenture
May 31, 2018
Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update
May 15, 2018
Therapix Biosciences Issues CEO's Letter to Shareholders
Mar 20, 2018
Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
Feb 07, 2018
Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected
Jan 09, 2018
Therapix Biosciences Announces Expansion into Precision Medicine Through New Fully-Owned Subsidiary and Provides Corporate Update Today at the Biotech Showcase(TM) 2018
Dec 04, 2017
Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program
Dec 04, 2017
Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program
Nov 21, 2017
Therapix Biosciences Spotlighted in Financial and Trade Media Outlets
Nov 10, 2017
Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids
Nov 02, 2017
Therapix Biosciences Third Quarter 2017 Conference Call and Webcast Scheduled for Thursday, November 9, 2017
Nov 02, 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Oct 18, 2017
Therapix Biosciences and Assuta Medical Center to Initiate Clinical Trial in Obstructive Sleep Apnea
Oct 06, 2017
Therapix Signs Formulation Development and Clinical Manufacturing Agreement with Catalent for THX-TS01
Sep 27, 2017
Therapix's First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study
Aug 03, 2017
Therapix Biosciences Second Quarter 2017 Conference Call and Webcast Scheduled for Thursday, August 10, 2017
Jun 27, 2017
Therapix Biosciences to Ring the Nasdaq Stock Market Opening Bell on June 28
Latest News
Apr 20, 2024
H2 Green Mining and Ohmium Sign Agreement to Boost Green Hydrogen in Chile
Apr 19, 2024
Churchill Serves as Sole Lead Arranger for a First Lien Credit Facility to Support Wynnchurch Capital’s...
Apr 19, 2024
Global Small Modular Reactor Market for Data Centers Industry Report 2024-2033: Hyperscale Data Centers to...
Apr 19, 2024
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market
Apr 19, 2024
Chemtrade Logistics Income Fund Declares April 2024 Distribution
Apr 19, 2024
MCR and BLT Complete $632 Million Refinancing of 53-Hotel Portfolio
Apr 19, 2024
Avangrid Thanks Southern Connecticut Gas Employee for 51 Years of Service
Apr 19, 2024
Construction Equipment Global Strategic Business Report 2024: Market to Reach $248.5 Billion by 2030 - Focus...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events